# ImmunityBio, Inc.: filings

IBRX · Nasdaq · CIK 1326110 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ibrx.md) · [Financials](/companies/ibrx/financials.md) · [Filings](/companies/ibrx/filings.md) · [Insiders](/companies/ibrx/insiders.md)

## Reports and events: 177 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 217, 8-K 99, 10-Q 34, 3 23, 424B5 14, CORRESP 13, 10-K 11, 144 11, 425 11, DEF 14A 11, SC 13D/A 10, UPLOAD 9, D 8, EFFECT 8, 5 6, S-1/A 6, S-8 6, DEFA14A 5, ARS 4, S-3 4, 3/A 3, DEF 14C 3, PRE 14C 3, SC 13G 3, SCHEDULE 13D/A 3, 4/A 2, POS AM 2, S-3ASR 2, SC 13G/A 2, 424B3 1, 424B4 1, 8-A12B 1, 8-K/A 1, AW 1, CERTNAS 1, CT ORDER 1, D/A 1, DEFM14A 1, DRS 1, POSASR 1, POS EX 1, S-1 1, S-1MEF 1, S-3/A 1, S-3MEF 1, S-4 1, S-4/A 1, S-8 POS 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 21:19 ET | [8-K](/filings/0001193125-26-421820.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-421820 |
| 2026-08-06 | 22:50 ET | [SCHEDULE 13D/A](/filings/0001193125-26-338651.md) | Ownership report, active investor, amended | 0001193125-26-338651 |
| 2026-08-04 | 11:45 ET | [10-Q](/filings/0001326110-26-000079.md) | Quarterly report, period 2026-06-30 | 0001326110-26-000079 |
| 2026-08-04 | 11:36 ET | [8-K](/filings/0001326110-26-000077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-26-000077 |
| 2026-07-30 | 21:19 ET | [8-K](/filings/0001326110-26-000071.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001326110-26-000071 |
| 2026-06-10 | 21:24 ET | [8-K](/filings/0001326110-26-000064.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001326110-26-000064 |
| 2026-05-18 | 21:20 ET | [8-K](/filings/0001193125-26-229153.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-229153 |
| 2026-05-07 | 11:37 ET | [10-Q](/filings/0001326110-26-000059.md) | Quarterly report, period 2026-03-31 | 0001326110-26-000059 |
| 2026-05-07 | 11:32 ET | [8-K](/filings/0001326110-26-000057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-26-000057 |
| 2026-04-30 | 23:48 ET | [DEF 14A](/filings/0001326110-26-000049.md) | Proxy statement, period 2026-06-09 | 0001326110-26-000049 |
| 2026-04-09 | 11:39 ET | [8-K](/filings/0001326110-26-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-26-000036 |
| 2026-04-06 | 12:03 ET | [8-K](/filings/0001193125-26-142932.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-142932 |
| 2026-03-31 | 12:24 ET | [8-K](/filings/0001193125-26-133363.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-133363 |
| 2026-02-25 | 02:51 ET | [SCHEDULE 13D/A](/filings/0001193125-26-072879.md) | Ownership report, active investor, amended | 0001193125-26-072879 |
| 2026-02-23 | 22:24 ET | [10-K](/filings/0001326110-26-000030.md) | Annual report, period 2025-12-31 | 0001326110-26-000030 |
| 2026-02-23 | 12:06 ET | [8-K](/filings/0001326110-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-26-000025 |
| 2026-02-18 | 14:02 ET | [8-K](/filings/0001326110-26-000018.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-26-000018 |
| 2026-01-26 | 12:00 ET | [8-K](/filings/0001326110-26-000014.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001326110-26-000014 |
| 2026-01-15 | 13:35 ET | [8-K](/filings/0001326110-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-26-000008 |
| 2026-01-14 | 13:42 ET | [8-K](/filings/0001326110-26-000004.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-26-000004 |
| 2025-12-29 | 00:25 ET | [8-K](/filings/0001193125-25-331244.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-331244 |
| 2025-12-15 | 21:25 ET | [8-K](/filings/0001326110-25-000146.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001326110-25-000146 |
| 2025-12-12 | 12:01 ET | [8-K](/filings/0001326110-25-000143.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-25-000143 |
| 2025-11-10 | 00:43 ET | [SCHEDULE 13D/A](/filings/0001193125-25-274843.md) | Ownership report, active investor, amended | 0001193125-25-274843 |
| 2025-11-05 | 02:53 ET | [10-Q](/filings/0001326110-25-000139.md) | Quarterly report, period 2025-09-30 | 0001326110-25-000139 |
| 2025-11-05 | 02:48 ET | [8-K](/filings/0001326110-25-000138.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-25-000138 |
| 2025-08-08 | 20:30 ET | [8-K](/filings/0001193125-25-177024.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-177024 |
| 2025-08-05 | 11:36 ET | [10-Q](/filings/0001326110-25-000114.md) | Quarterly report, period 2025-06-30 | 0001326110-25-000114 |
| 2025-08-05 | 11:17 ET | [8-K](/filings/0001326110-25-000112.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-25-000112 |
| 2025-07-25 | 10:23 ET | [8-K](/filings/0001193125-25-164789.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-164789 |
| 2025-06-20 | 20:39 ET | [8-K](/filings/0001326110-25-000084.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001326110-25-000084 |
| 2025-05-12 | 10:46 ET | [10-Q](/filings/0001326110-25-000071.md) | Quarterly report, period 2025-03-31 | 0001326110-25-000071 |
| 2025-05-12 | 10:40 ET | [8-K](/filings/0001326110-25-000069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-25-000069 |
| 2025-05-05 | 11:15 ET | [8-K](/filings/0001193125-25-112057.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-112057 |
| 2025-04-30 | 22:22 ET | [DEF 14A](/filings/0001326110-25-000054.md) | Proxy statement, period 2025-06-18 | 0001326110-25-000054 |
| 2025-04-15 | 12:10 ET | [8-K](/filings/0001326110-25-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-25-000044 |
| 2025-04-08 | 11:45 ET | [8-K](/filings/0001193125-25-075102.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-075102 |
| 2025-03-19 | 12:14 ET | [8-K](/filings/0001326110-25-000040.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001326110-25-000040 |
| 2025-03-03 | 12:47 ET | [10-K](/filings/0001326110-25-000033.md) | Annual report, period 2024-12-31 | 0001326110-25-000033 |
| 2025-03-03 | 12:42 ET | [8-K](/filings/0001326110-25-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-25-000031 |
| 2025-02-13 | 02:16 ET | [8-K](/filings/0001193125-25-025324.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-025324 |
| 2025-02-07 | 21:52 ET | [8-K](/filings/0001193125-25-022776.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-022776 |
| 2024-12-11 | 12:46 ET | [8-K](/filings/0001193125-24-274871.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-274871 |
| 2024-12-10 | 22:28 ET | [8-K](/filings/0001193125-24-274438.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-274438 |
| 2024-11-19 | 13:01 ET | [8-K](/filings/0001326110-24-000115.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-24-000115 |
| 2024-11-12 | 12:30 ET | [10-Q](/filings/0001326110-24-000111.md) | Quarterly report, period 2024-09-30 | 0001326110-24-000111 |
| 2024-11-12 | 12:25 ET | [8-K](/filings/0001326110-24-000109.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-24-000109 |
| 2024-08-12 | 12:03 ET | [10-Q](/filings/0001326110-24-000103.md) | Quarterly report, period 2024-06-30 | 0001326110-24-000103 |
| 2024-07-18 | 01:48 ET | [8-K](/filings/0001326110-24-000093.md) | 1.01 Entry into a material agreement | 0001326110-24-000093 |
| 2024-06-12 | 20:36 ET | [8-K](/filings/0001326110-24-000069.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001326110-24-000069 |

Page 1 of 4. [Older](/companies/ibrx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.